Wednesday, 23 October 2019

Eli Lilly to target cancer drug developers for deals

Eli Lilly and Co will target cancer drug developers for deals, Chief Executive Officer Dave Ricks said on a post-earnings conference call on Wednesday.


No comments:

Post a Comment